Gemcitabine/carboplatin in advanced urothelial cancer

被引：16
|
作者：
Carles, J
Nogué, M
机构：
[1] Univ Autonoma Barcelona, Hosp Mar, Oncol Unit, E-08003 Barcelona, Catalonia, Spain
[2] Consorci Hosp Parc Tauli, Oncol Unit, Sabadell, Spain
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 03期
关键词：
D O I：
10.1053/sonc.2001.22537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 24
页数：6
相关论文
共 50 条
  • [21] SEQUENTIAL CHEMOTHERAPY WITH GEMCITABINE PLUS CARBOPLATIN, FOLLOWED BY ADDITIONAL DOCETAXEL FOR AGED PATIENTS WITH ADVANCED UPPER-TRACT UROTHELIAL CANCER
    Yoneyama, Takahiro
    Hagiwara, Kazuhisa
    Narita, Takuma
    Oikawa, Masaaki
    Sugiyama, Naoki
    Suzuki, Yuuichirou
    Yamamoto, Hayato
    Okamoto, Akiko
    Tobisawa, Yuuki
    Yoneyama, Tohru
    Imai, Atsushi
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2013, 189 (04): : E285 - E286
  • [22] Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
    Bi, Feng
    Li, Han-Zhong
    Zhu, Shaoxing
    Zou, Qing
    Tang, Jia
    Zhang, Wei
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer
    Fountzilas, G
    Athanassiades, A
    Kalogera-Fountzila, A
    Samantas, E
    Bacoyiannis, C
    Briassoulis, E
    Pavlidis, N
    Kosmidis, P
    Skarlos, D
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S28 - S32
  • [24] Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Zatloukal, P
    Petruzelka, L
    LUNG CANCER, 2002, 38 : S33 - S36
  • [25] Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer
    Dudek, Arkadiusz Z.
    Larson, Timothy
    Keshtgarpour, Mani
    Kumar, Priya
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (05): : 481 - 486
  • [26] COMBINATION THERAPY CONSISTING OF GEMCITABINE, CARBOPLATIN, AND DOCETAXEL (GCD) AS AN ACTIVE TREATMENT FOR ADVANCED UROTHELIAL CELL CARCINOMA
    Tsuruta, Hiroshi
    Horikawa, Yohei
    Narita, Shintaro
    Saito, Mitsuru
    Obara, Takashi
    Numakura, Kazuyuki
    Sato, Shigeru
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2010, 183 (04): : E659 - E659
  • [27] Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for aged patients with advanced upper-tract urothelial cancer.
    Yoneyama, Takahiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [28] Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder
    Scosyrev, Emil
    Messing, Edward M.
    van Wijngaarden, Edwin
    Peterson, Derick R.
    Sahasrabudhe, Deepak
    Golijanin, Dragan
    Fisher, Susan G.
    CANCER, 2012, 118 (01) : 72 - 81
  • [29] Quality of life during gemcitabine plus cisplatin or gemcitabine plus carboplatin for urothelial carcinoma
    Hatakeyama, S.
    Yoneyama, T.
    Hashimoto, Y.
    Koie, T.
    Ohyama, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [30] Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma
    Sugimoto, Kazuma
    Taguchi, Satoru
    Kishitani, Kenjiro
    Kawai, Taketo
    Masuda, Kazuki
    Nakamura, Yu
    Kinjo, Manami
    Tambo, Mitsuhiro
    Miyakawa, Jimpei
    Akiyama, Yoshiyuki
    Yamada, Yuta
    Sato, Yusuke
    Yamada, Daisuke
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Kume, Haruki
    BMC UROLOGY, 2022, 22 (01)
12345